Iridex (IRIX) Revenue Growth (1y) (2011 - 2026)
Iridex (IRIX) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 6.08% |
| 10 | Iridex | 15.45 Mn | 10.86 Mn | 4.74 Mn | -0.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -0.82% |
| Jan 3, 2026 | 15.97% |
| Sep 27, 2025 | 7.80% |
| Jun 28, 2025 | 7.44% |
| Mar 29, 2025 | 1.15% |
| Dec 28, 2024 | 1.91% |
| Sep 28, 2024 | -9.88% |
| Jun 29, 2024 | -1.74% |
| Mar 30, 2024 | -14.19% |
| Dec 30, 2023 | -18.01% |
| Sep 30, 2023 | -12.20% |
| Jul 1, 2023 | -6.54% |
| Apr 1, 2023 | 2.38% |
| Dec 31, 2022 | -49.11% |
| Oct 1, 2022 | 10.34% |
| Jul 2, 2022 | 2.45% |
| Apr 2, 2022 | 11.94% |
| Oct 2, 2021 | 50.68% |
| Jul 3, 2021 | 115.89% |
| Apr 3, 2021 | 32.57% |